ResearcherShenyang Pharmaceutical UniversityActive in the last 2 years
Enlong Ma
Matched on ORCID iD 0000-0002-6042-7212; OpenAlex author ID A5049332951.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 5
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 4
- Riboflavin protects against pancreatic cancer metastasis by targeting TGF-β receptor 1. Last author DOI 10.1016/j.bioorg.2024.107274↗
- Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells. Co-author DOI 10.1016/j.bmcl.2022.129087↗
- ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S. Co-author DOI 10.1016/j.cbi.2022.109811↗
- Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation. Last author DOI 10.1016/j.bioorg.2020.103679↗
Closest collaborators
The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Juanping Zhao · 3 shared papers, 2022–2024
- Paper Riboflavin protects against pancreatic cancer metastasis by targeting TGF-β receptor 1. DOI 10.1016/j.bioorg.2024.107274↗
- Paper Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer c… DOI 10.1016/j.bmcl.2022.129087↗
- Paper ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S. DOI 10.1016/j.cbi.2022.109811↗
- Yanchun Li · 3 shared papers, 2020–2024
- Paper Riboflavin protects against pancreatic cancer metastasis by targeting TGF-β receptor 1. DOI 10.1016/j.bioorg.2024.107274↗
- Paper ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S. DOI 10.1016/j.cbi.2022.109811↗
- Paper Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening… DOI 10.1016/j.bioorg.2020.103679↗
- Lei Yuan · 3 shared papers, 2020–2023
- Paper Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer c… DOI 10.1016/j.bmcl.2022.129087↗
- Paper ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S. DOI 10.1016/j.cbi.2022.109811↗
- Paper Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening… DOI 10.1016/j.bioorg.2020.103679↗
- Haoqiang Huang · 1 shared paper, 2023
- Haoxuan Song · 1 shared paper, 2020
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.